Reprogramming brain cells to restore vision after a stroke

Researchers Explore Gene Therapy to Restore Vision After Stroke About one-third of stroke survivors experience some degree of vision loss. For many patients, the condition can be life-changing. Vision often does not fully recover, and few effective treatment options exist. New research from teams at Purdue University and Jinan University offers hope that gene therapy … Continue reading Reprogramming brain cells to restore vision after a stroke

National Academy of Medicine honors CIRM Grantees

As someone who doesn’t always send birthday cards on time, I’m used to offering belated congratulations. So I have no shame in sending them now to four CIRM grantees elected to the National Academy of Medicine in 2020. I say four, but it’s really three and a half. I’ll explain why in a moment. Being … Continue reading National Academy of Medicine honors CIRM Grantees

Freezing hope for people with dry age-related macular degeneration

A retina of a patient with macular degeneration. (Photo credit: Paul Parker/SPL) A new cryopreservation technique could help make a promising cell therapy for dry age-related macular degeneration (AMD) more widely available. Researchers supported by the California Institute for Regenerative Medicine (CIRM) developed a way to freeze retinal implants. The process could extend shelf life … Continue reading Freezing hope for people with dry age-related macular degeneration

Two voices, one message, watch out for predatory stem cell clinics

Last week, two new papers came out echoing each other about the dangers of bogus “therapies” being offered by predatory stem cell clinics and the risks they pose to patients. Unapproved Interventions The first was from the Pew Charitable Trusts The Pew report is titled “Unapproved Stem Cell Interventions Highlight Need for Greater FDA Enforcement,” … Continue reading Two voices, one message, watch out for predatory stem cell clinics

71 for Proposition 71

Proposition 71 is the state ballot initiative that created California's Stem Cell Agency. This month, the Agency reached another milestone when the 71st clinical trial was initiated in the CIRM Alpha Stem Cell Clinics (ASCC) Network. The ASCC Network deploys specialized teams of doctors, nurses and laboratory technicians to conduct stem cell clinical trials at … Continue reading 71 for Proposition 71

CIRM Invests in New Therapies for HIV, Blindness, Leukemia, and Sickle Cell Disease

The California Institute for Regenerative Medicine (CIRM) Board has approved funding for a range of stem cell and gene therapy programs. The awards support projects targeting HIV, blindness, leukemia, hearing loss, autism, and sickle cell disease. Together, they reflect CIRM's commitment to advancing promising discoveries toward new treatments for patients. Advancing a Potential Cure for … Continue reading CIRM Invests in New Therapies for HIV, Blindness, Leukemia, and Sickle Cell Disease

A Patient Advocate’s Personal Manifesto

Janni Lehrer-Stein was just 26 when she was diagnosed with a degenerative eye disease and told she was going to be blind within six months. The doctor who gave her the news told her “But don’t worry, people like you are usually hit and killed by a bus long before they go completely blind.” At … Continue reading A Patient Advocate’s Personal Manifesto

jCyte gets FDA go-ahead for Fast Track review process of Retinitis Pigmentosa stem cell therapy

When the US Congress approved, and President Obama signed into law, the 21st Century Cures Act last year there was guarded optimism that this would help create a more efficient and streamlined, but no less safe, approval process for the most promising stem cell therapies. Even so many people took a wait and see approach, … Continue reading jCyte gets FDA go-ahead for Fast Track review process of Retinitis Pigmentosa stem cell therapy

jCyte starts second phase of stem cell clinical trial targeting vision loss

Studies show that Americans fear losing their vision more than any other sense, such as hearing or speech, and almost as much as they fear cancer, Alzheimer’s and HIV/AIDS. That’s not too surprising. Our eyes are our connection to the world around us. Sever that connection, and the world is a very different place. For … Continue reading jCyte starts second phase of stem cell clinical trial targeting vision loss

California’s stem cell agency rounds up the year with two more big hits

It’s traditional to end the year with a look back at what you hoped to accomplish and an assessment of what you did. By that standard 2016 has been a pretty good year for us at CIRM. Yesterday our governing Board approved funding for two new clinical trials, one to help kidney transplant patients, the … Continue reading California’s stem cell agency rounds up the year with two more big hits